Immunic, Inc.IMUXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
5Y CAGR+4.1%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
+4.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$6.06M+346.7%
2024$-2.46M-143.8%
2023$5.61M+710.6%
2022$-919000.00+28.2%
2021$-1.28M-125.8%
2020$4.95M+136.0%
2019$2.10M+361.3%
2018$455000.00-21.1%
2017$577000.00+94.3%
2016$297000.00-